Use of IUCLID 4 by authorities - PowerPoint PPT Presentation

1 / 6
About This Presentation
Title:

Use of IUCLID 4 by authorities

Description:

(c) The formats made available by the Commission must be used for submission ... in order to avoid overlooking errors in IUCLID of influence on the selection of ... – PowerPoint PPT presentation

Number of Views:79
Avg rating:3.0/5.0
Slides: 7
Provided by: Hauzen
Category:

less

Transcript and Presenter's Notes

Title: Use of IUCLID 4 by authorities


1
Use of IUCLID 4 by authorities
Seminar for Biocides Authorities, Sofia, 19 April
2006 Elisabeth Fassold Expert Centre Biocides
2
IUCLID Requirement
  • REVIEW PROGRAMME, Reg. 2032/2003
  • Annex IV, Requirements for the summary dossier
  • (c) The formats made available by the Commission
    must be used for submission of the dossiers. In
    addition, the special software package (IUCLID)
    made available by the Commission must be used for
    those parts of the dossiers to which IUCLID
    applies. Formats and further guidance on data
    requirements and dossier preparation are
    available on the ECB homepage at
    http//ecb.jrc.it/biocides.
  • NEW BIOCIDAL SUBSTANCES, BPD
  • a IUCLID file is not part of the formal, legal
    requirements !

3
Use of IUCLID, usefulness of IUCLID?
  • TNsG on Dossier Preparation and Study Evaluation
    (TNsG DPSE)
  • IUCLID applies to all studies performed on active
    biocidal substances
  • IUCLID is supplement to Doc III
  • IUCLID format version 4 is not detailed
  • Reporting requirements in IUCLID key results and
    indication of study validity
  • for key-studies or studies for which more
    detailed information is necessary Doc III-study
    summaries have to be provided in addition

4
Use of IUCLID
  • For the completeness check phase the TNsG DPSE
    proposes
  • IUCLID study summaries to be used by the RMS as
    the basis for checking the selection of key
    study(ies)
  • all key studies must also be entered into IUCLID
  • TM Biocides proposes
  • in order to avoid overlooking errors in IUCLID of
    influence on the selection of the key study(ies)
  • IUCLID study summaries not the sole basis for
    checking the selection of key study(ies), but
  • RMS also look into the original studies
    (Doc-level IV) to check their relevance and
    results
  • For in-depth evaluation of the key study(ies) TM
    proposes
  • in case of questions for a specific endpoint or a
    specific effect, refer to IUCLID and evaluate
    other original studies more closely

5
Responsibility for data submitted in IUCLID
  • IUCLID is part of the summary dossier
  • not part of the all-in-one-approach !
  • no RMS version of the CA (for the CA report) !
  • no active work of RMSs in the IUCLID dataset in
    the evaluation phase !
  • accurateness of reporting and reliability of the
    data in IUCLID throughout the process remain with
    the participant !
  • but RMS may ask the participant to update the
    information in IUCLID in case of contradiction to
    Doc-level IV test report
  • for searchability after inclusion in, at least,
    local IUCLID software, it should be in electronic
    form as .exp file and in paper as pdf print-out

6
IUCLID-updates to final version
  • IUCLID is not contained in the CAs reports
  • but participant to provide a correct and
    comprehensive final IUCLID version
  • after formal finalisation of dossier evaluation
    by the RMS and prior to Annex I/IA (non)inclusion
    has been decided on EU level
  • TM proposal that final version of the IUCLID
    dataset is provided to the RMS within three
    months after the dispatch of the CA report to the
    Commission not effectively applied across RMS
    and
  • RMS or the Commission to ask the participant for
    it ?
Write a Comment
User Comments (0)
About PowerShow.com